$HCA

HCA Healthcare, Inc.

3
3
0

No SEC Form 4 filings for $HCA in the last 30 days.

Low

HCA Healthcare, Inc. $HCA Shares Sold by Rathbones Group PLC

Rathbones Group PLC decreased its stake in HCA Healthcare (NYSE:HCA) by 12.2% in the fourth quarter, selling 5,532 shares and retaining 39,771 shares valued at $18.6 million. Despite HCA reporting mixed first-quarter earnings with a slight revenue beat but an EPS miss, Wall Street analysts maintain a "Moderate Buy" rating for the company. HCA Healthcare also announced a quarterly dividend of $0.78 per share, reflecting confidence from the company.

5,006 Shares in ResMed Inc. $RMD Acquired by North Dakota State Investment Board

The North Dakota State Investment Board recently acquired 5,006 shares of ResMed Inc. (NYSE:RMD), valued at approximately $1.2 million, during the fourth quarter. This acquisition comes as ResMed reported strong quarterly results, exceeding analyst expectations for both EPS and revenue, and announced a quarterly dividend of $0.60 per share. Several other institutional investors have also adjusted their holdings in ResMed, while analysts maintain a "Moderate Buy" consensus rating for the stock despite recent insider selling.

Fideuram Intesa Sanpaolo Private Banking S.P.A. Invests $5.50 Million in HCA Healthcare, Inc. $HCA

Fideuram Intesa Sanpaolo Private Banking S.P.A. recently invested $5.50 million in HCA Healthcare, Inc., acquiring 11,777 shares in the fourth quarter. This move highlights continued institutional interest in HCA, with hedge funds and institutions holding a significant portion of the company's stock. Despite recent price target adjustments by analysts, HCA Healthcare maintains a "Moderate Buy" consensus rating with an average target price of $515.77.